Sally Stenning

17.7k total citations · 3 hit papers
120 papers, 11.5k citations indexed

About

Sally Stenning is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sally Stenning has authored 120 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 45 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Sally Stenning's work include Testicular diseases and treatments (46 papers), Gastric Cancer Management and Outcomes (18 papers) and Urologic and reproductive health conditions (16 papers). Sally Stenning is often cited by papers focused on Testicular diseases and treatments (46 papers), Gastric Cancer Management and Outcomes (18 papers) and Urologic and reproductive health conditions (16 papers). Sally Stenning collaborates with scholars based in United Kingdom, Netherlands and Norway. Sally Stenning's co-authors include Ruth E. Langley, William Allum, David Cunningham, Stephen Falk, Monica Verma, J N Thompson, Yu Jo Chua, Timothy Iveson, M. Nicolson and Cornelis J.�H. van de Velde and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Sally Stenning

117 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

2006 4.5k citations David Cunningham, William Allum et al. New England Journal of Medicine profile →
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

2009 721 citations William Allum, Sally Stenning et al. Journal of Clinical Oncology profile →
Mismatch Repair Deficiency, Microsatellite Instability, and Survival

2017 365 citations Elizabeth Smyth, Andrew Wotherspoon et al. profile →

Peers

Countries citing papers authored by Sally Stenning

Since Specialization

Citations

This map shows the geographic impact of Sally Stenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Stenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Stenning more than expected).

Fields of papers citing papers by Sally Stenning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Stenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Stenning. The network helps show where Sally Stenning may publish in the future.

Co-authorship network of co-authors of Sally Stenning

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Stenning. A scholar is included among the top collaborators of Sally Stenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Stenning. Sally Stenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review 2021 ·Clinical Trials ·William J Cragg, Caroline Hurley, (unknown), Sally Stenning	6
2	Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMPER triggered monitoring study 2020 ·Clinical Trials ·William J Cragg, Caroline Hurley, (unknown), Sally Stenning	1
3	Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy 2017 ·Clinical Cancer Research ·Elizabeth Smyth, Shenli Zhang, David Cunningham, Andrew Wotherspoon, Richie Soong, Clare Peckitt, Nicola Valeri, Matteo Fassan, Massimo Rugge, Alicia Okines, William Allum, Sally Stenning, Matthew Nankivell, Ruth E. Langley, Patrick Tan	9
4	ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis 2017 ·Annals of Oncology ·(unknown), Iain A. McNeish, Andrew Dean, David Gallardo, (unknown), Dearbhaile M. O’Donnell, Jane Hook, C. Coyle, Sarah P. Blagden, James D. Brenton, Raj Naik, Timothy Perren, Sudha Sundar, Adrian Cook, Elizabeth C James, Ann Marie Swart, Sally Stenning, Richard Kaplan, Jonathan A. Ledermann	38
5	Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma 2015 ·Clinical Cancer Research ·Duncan C. Gilbert, Reem Al‐Saadi, Khin Thway, Ian Chandler, Daniel M. Berney, Rhian Gabe, Sally Stenning, Joan Sweet, Robert Huddart, Janet Shipley	18
6	Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214) 2011 ·Journal of Clinical Oncology ·R. Timothy D. Oliver, Graham M. Mead, Gordon Rustin, Johnathan Joffe, Nina Aass, Robert L. Coleman, Rhian Gabe, Philip Pollock, Sally Stenning	178
7	Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma 2010 ·Journal of Clinical Oncology ·Michael Brada, Sally Stenning, Rhian Gabe, Lindsay C Thompson, David E. Levy, R. Rampling, Sara Erridge, Frank Saran, Rao Gattamaneni, Kirsten Hopkins, (unknown), V. Peter Collins, Siow Ming Lee	178
8	Myeloablative therapy for recurrent Hodgkin lymphoma: Good success rates irrespective of previous treatments in the UKLG LY09 trial (ISRCTN97144519) 2008 ·ePrints Soton (University of Southampton) ·(unknown), Matthew R. Sydes, Bruno C. Hancock, M.H. Cullen, Sally Stenning, John Radford	2
9	¹⁸ Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22—The NCRI Testis Tumour Clinical Study Group 2007 ·Journal of Clinical Oncology ·Robert Huddart, Michael O’Doherty, Anwar R. Padhani, Gordon Rustin, Graham M. Mead, Johnathan Joffe, P. Vasey, Stephen Harland, John Logue, Gedske Daugaard, Sharon F. Hain, S Kirk, Jane E. Mackewn, Sally Stenning	68
10	Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer breakdown → 2006 ·New England Journal of Medicine ·David Cunningham, William Allum, Sally Stenning, J N Thompson, Cornelis J.�H. van de Velde, M. Nicolson, J.H. Scarffe, F. Lofts, Stephen Falk, Timothy Iveson, David B. Smith, Ruth E. Langley, Monica Verma, Simon Weeden, Yu Jo Chua	4494
11	Radical prostatectomy: pathology compared with other major series findings in 1001 cases and over time 2005 ·UCL Discovery (University College London) ·(unknown), (unknown), Sally Stenning, Jonathan E. Cohen, (unknown), (unknown)	0
12	Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning 2004 ·British Journal of Cancer ·(unknown), Ewout W. Steyerberg, Sally Stenning, Elise Dusseldorp, J. Dik F. Habbema	17
13	Radiotherapy for malignant gliomas in the elderly 2003 ·Seminars in Oncology ·Michael Brada, Sally Stenning	7
14	High-dose versus conventional-dose chemotherapy asfirst-salvage treatment in patients with non-seminomatousgerm-cell tumors: a matched-pair analysis 2002 ·Annals of Oncology ·J. Beyer, Sally Stenning, A. Gerl, S.D. Fosså, W. Siegert	78
15	Is 3BEP equivalent to 3BEP+1EP in good prognosis germ cell cancer? An EORTC/MRC phase III study 1999 ·UCL Discovery (University College London) ·Ronald de Wit, (unknown), Paul Wilkinson, PHM de Mulder, G.M. Mead, S.D. Fosså, PS Cook, Linda de Prijck, Sally Stenning, Laurence Collette	3
16	High-dose versus conventional-dose first-salvage treatment in nonseminoma: a matched-pair analysis 1999 ·UCL Discovery (University College London) ·J. Beyer, Sally Stenning, A. Gerl, S. D. Fosså, (unknown)	11
17	Use of Different Outcome Measures in Randomised Studies of Malignant Glioma can Significantly Alter the Interpretation of Time to Progression: Reanalysis of the MRC BR2 Study 1999 ·Journal of Neuro-Oncology ·Jeremy Chataway, Sally Stenning, Norman M. Bleehen, Robert A. Grant	1
18	Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study. 1998 ·Journal of Clinical Oncology ·Stan B. Kaye, Graham M. Mead, Sophie D. Fosså, M.H. Cullen, R deWit, I. Bodrogi, C. van Groeningen, Richard Sylvester, Laurence Collette, Sally Stenning, Linda de Prijck, Élodie Lallemand, (unknown)	120
19	What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? 1998 ·British Journal of Cancer ·P. Price, Peter Hoskin, (unknown), Sally Stenning	7
20	The accuracy of volumetric measurement of high-grade gliomas 1989 ·Clinical Radiology ·(unknown), Sally Stenning, (unknown)	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact